Late Toxicity of Moderately Hypofractionated Intensity-Modulated Proton Therapy Treating the Prostate and Pelvic Lymph Nodes for High-Risk Prostate Cancer-Reference-Cited by-同舟云学术

Late Toxicity of Moderately Hypofractionated Intensity-Modulated Proton Therapy Treating the Prostate and Pelvic Lymph Nodes for High-Risk Prostate Cancer

Published:2023-04 Issue:5 Volume:115 Page:1085-1094
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Choo Richard^ORCID,Hillman David W.,Mitchell Cecilia,Daniels Thomas,Vargas Carlos,Rwigema Jean Claude,Corbin Kimberly,Keole Sameer,Vora Sujay,Merrell Kenneth,Stish Bradley,Pisansky Thomas,Davis Brian J.,Amundson Adam,Wong William

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference20 articles.

1. IMPT versus VMAT for Pelvic Nodal Irradiation in Prostate Cancer: A Dosimetric Comparison;Whitaker;Int J Part Ther,2019

2. Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer;Pollack;J Clin Oncol,2013

3. Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer;Catton;J Clin Oncol,2017

4. Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer;Lee;J Clin Oncol,2016

5. Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): Final efficacy results from a randomised, multicentre, open-label, phase 3 trial;Incrocci;Lancet Oncol,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton versus photon therapy for high-risk prostate cancer with dose escalation of dominant intraprostatic lesions: a preliminary planning study;Frontiers in Oncology;2023-11-08

2. Plan robustness evaluation strategies in whole-pelvic proton therapy for high-risk prostate cancer patients within a randomised clinical trial;Acta Oncologica;2023-09-29

3. Proton therapy planning and image-guidance strategies within a randomized controlled trial for high-risk prostate cancer;Clinical and Translational Radiation Oncology;2023-07